JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC
Matthew J. Grimshaw, Barbara Ann Burtness, Davinder S. Theti, Riham Iadevaia et al.
Journal
Future Oncology
Topics
Lung Cancer Treatments and Mutations
article
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC
Matthew J. Grimshaw, Barbara Ann Burtness, Davinder S. Theti, Riham Iadevaia, Arindam Dhar, Lei Hua, Nabil Saba, K. Harrington, Gordana Vlahovic, Makoto Tahara, Gary P. Carlson, Amanda Psyrri, Lillian L. Siu, Jean-Pascal Machiels
article en
Abstract
No abstract available for this paper.
Publication Tag
Future OncologyVol. 22(3)
Institutions
Cliniques Universitaires Saint-Luc (BE), Emory University (US), Princess Margaret Cancer Centre (CA), Yale University (US), Royal Marsden Hospital (GB), University General Hospital Attikon (GR), National Cancer Center Hospital East (JP), UCLouvain (BE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC — Matthew J. Grimshaw, Barbara Ann Burtness, et al. · Future Oncology (2026) | TGRS Research Map | TGRS